Sector Update: Health Care

MT Newswires12/04 04:21

Top Midday Decliners

MT Newswires12/04 02:45

Why Revelation Biosciences (REVB) Stock Is Down 38%

Benzinga12/04 00:00

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Businesswire12/03 21:38

The FDA Has Accepted Revelation Biosciences' Investigational New Drug Application To Initiate Phase 1b Study To Evaluate Gemini As A Preconditioning Treatment In Chronic Kidney Disease Patients, Study To Start In Early 2025

Benzinga12/02 19:03

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Businesswire12/02 19:00